Shenzhen Hepalink Pharmaceutical Group Co., Ltd. released its monthly return for November 2025. According to the announcement, the authorized share capital of H shares (stock code 09989) and A shares (stock code 002399) remained at 220,094,500 shares and 1,247,201,704 shares respectively, with a total authorized share capital of RMB 1,467,296,204. No increases or reductions were recorded during the period.

The announcement shows that the number of issued shares for both H shares and A shares also remained unchanged at 220,094,500 and 1,247,201,704 shares respectively, and there were no treasury shares. The company reported no share options, warrants, convertibles, or other share issuance arrangements for the month.